Chemoinformaics analysis of (3R,6R)-6-ethenyl-2,2,6-trimethyloxan-3-yl acetate
Molecular Weight | 212.289 | nRot | 2 |
Heavy Atom Molecular Weight | 192.129 | nRig | 8 |
Exact Molecular Weight | 212.141 | nRing | 1 |
Solubility: LogS | -2.536 | nHRing | 1 |
Solubility: LogP | 2.229 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 35.7819 |
nHD | 0 | BPOL | 24.4041 |
QED | 0.521 |
Synth | 3.8 |
Natural Product Likeliness | 3.074 |
NR-PPAR-gamma | 0.026 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.04 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.442 |
MDCK | 0.0000263 |
BBB | 0.818 |
PPB | 0.741089 |
VDSS | 1.624 |
FU | 0.386556 |
CYP1A2-inh | 0.048 |
CYP1A2-sub | 0.371 |
CYP2c19-inh | 0.062 |
CYP2c19-sub | 0.899 |
CYP2c9-inh | 0.047 |
CYP2c9-sub | 0.428 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.597 |
CYP3a4-inh | 0.262 |
CYP3a4-sub | 0.399 |
CL | 3.261 |
T12 | 0.75 |
hERG | 0.011 |
Ames | 0.125 |
ROA | 0.012 |
SkinSen | 0.566 |
Carcinogencity | 0.668 |
EI | 0.972 |
Respiratory | 0.039 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.593192 |